Safety, Efficacy and Pharmacokinetics of CBT-008 in Patients With Meibomian Gland Dysfunction
Clinical trial NCT05261386 · COMPLETED
Trial details
- NCT number
- NCT05261386
- Sponsor
- Cloudbreak Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-04
- Primary completion
- 2022-09-07
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.